TG Therapeutics Inc (TGTX) — Long-term Investment Intensity
TG Therapeutics Inc (TGTX) has a Long-term Investment Intensity of 5.7% as of March 2026. Long-term investments of $87.88 Million represent 5.7% of total assets of $1.53 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check cash flow reinvestment rate of TG Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
TG Therapeutics Inc Long-term Investment Intensity (2013–2025)
This chart shows how TG Therapeutics Inc's Long-term Investment Intensity has evolved across 6 annual periods from 2013 to 2025. As of March 2026, the intensity stands at 5.7%, reflecting long-term investments of $87.88 Million against total assets of $1.53 Billion USD. Explore TG Therapeutics Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for TG Therapeutics Inc (2013–2025)
The table below presents the year-by-year Long-term Investment Intensity for TG Therapeutics Inc from 2013 to 2025, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market cap of TG Therapeutics Inc.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 7.0% | $74.83 Million | $1.06 Billion | ▲ +6.9 pp |
| 2024 | 0.1% | $808.00K | $577.69 Million | ▼ -6.3 pp |
| 2022 | 6.4% | $12.40 Million | $193.57 Million | ▼ -3.0 pp |
| 2021 | 9.4% | $35.53 Million | $379.63 Million | ▼ -12.7 pp |
| 2015 | 22.0% | $25.00 Million | $113.47 Million | ▲ +11.8 pp |
| 2013 | 10.2% | $4.92 Million | $48.11 Million | — |